Whereas ADAMTS-13 activity levels less than 10% can cause TTP, low levels that fall within the normal range (lowest quartile) are associated with increased risk of developing ischemic stroke [208–210]. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.